MicroRNA Binding Site Polymorphisms as Biomarkers in Cancer Management and Research

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s61693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

SNPing Cancer in the Bud: MicroRNA and microRNA-target Site Polymorphisms as Diagnostic and Prognostic Biomarkers in Cancer

Pharmacology and Therapeutics
Pharmacology
2013English

SNPs in MicroRNA Binding Sites as Prognostic and Predictive Cancer Biomarkers

Critical Reviews in Oncogenesis
2013English

MicroRNA Machinery Genes as Novel Biomarkers for Cancer

Frontiers in Oncology
Cancer ResearchOncology
2014English

Single Nucleotide Polymorphisms as Biomarkers for Drug Response and Toxicity in the Management of Colorectal Cancer

Journal of Pharmacogenomics & Pharmacoproteomics
2018English

MicroRNA-21 and microRNA-30c as Diagnostic Biomarkers for Prostate Cancer: A Meta-Analysis

Cancer Management and Research
Oncology
2019English

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2013English

MicroRNA as Potential Biomarkers in Glioblastoma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2015English

Circulating microRNA-92a and microRNA-21 as Novel Minimally Invasive Biomarkers for Primary Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

MicroRNA Polymorphisms and Risk of Colorectal Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy